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Prevalence of hypovitaminosis D in Western populations is high; pregnant women are identified as a high-risk group, especially if dark skinned.
Consequences of severe clinical vitamin D deficiency in pregnancy can be life threatening to the newborn, while lesser degrees of hypovitaminosis
D may have important long-term implications for offspring health. Past experiences with routine provision of 10mg/d (400 IU/d) to all pregnant
mothers suggest that this dose is sufficient to prevent overt neonatal complications of vitamin D deficiency. Recent data suggest that supplemen-
tation with dosages above 10mg/d may be required for optimal health in the mother and child; however, further research is required for the assess-
ment of the benefits and safety of supplementation with higher dosages. Lack of unified advice on vitamin D supplementation of pregnant mothers
in the UK hinders the implementation of primary prevention strategies and is likely to leave some deficient mothers without supplementation.
Vitamin D: Pregnancy: Deficiency: Policy
Mothers have protected their babies from rickets by spending
time outdoors and taking cod liver oil for almost 100 years,
from before vitamin D was discovered. Now that avoidance
of mid-day sunlight is advised, and cod liver oil is no longer
used in pregnancy, we have seen rickets and other features
of vitamin D deficiency re-emerge(1).
What is the scale of the problem in the UK?
Hypovitaminosis D affects adults in epidemic proportions
in Western societies(2,3), which is a problem aggravated
by Western lifestyles with long hours of indoor work and by
avoidance of sunshine aimed at reduction in skin cancer risks
(Table 1). Vitamin D deficiency (,25 nmol/l) is more common
in women than in men (for example, 9·2 v. 6·6 %, respectively,
in British 45-year-olds)(4), and pregnancy is known to represent
a particularly high-risk situation. However, as we will discuss
in the following section, in the UK, there is currently no
consensus on advice on vitamin D supplementation to pregnant
women or generally agreed guidelines for relevant health care
providers. Lack of consistent guidance leads to mixed messages,
which make it difficult to effectively implement strategies
for the primary prevention of vitamin D deficiency.
The return of rickets in the UK
There is a long history of population-based approaches for
the prevention of vitamin D deficiency in Britain(5). By the
mid-19th century, it was appreciated that rickets was
prevented and cured by summer sunshine or by taking cod
liver oil(6). The discovery of vitamin D in the 1920s led to regular
outdoor ‘airing’ of infants and routine cod liver oil consumption
by many mothers and children(5,6). Indeed, neonatal/infantile
hypocalcaemia and rickets had virtually disappeared by the
1930s. As a result of this knowledge, ergocalciferol was added
to National Dried Milk during World War II, and cod liver oil
was included as one of the five welfare foods distributed by
the Ministry of Food to expectant/nursing mothers and young
children(7). Since World War II, vitamin D supplementation
has been consistently recommended during pregnancy(5,8,9).
However, after the war, uncontrolled vitamin D fortification of
baby milks and baby foods provided intakes of up to 100mg/d
(4000 IU/d), which caused many cases of infantile hypercalcae-
mia(5,10,11). Uncontrolled vitamin D fortification was then
banned(11), followed by resurgence of rickets in immigrant
communities during the 1960s(5,12,13). Cod liver oil remained
available at antenatal clinics, but uptake was poor in immigrant
populations(14). Routine offers of cod liver oil (rich in vitamin A)
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to pregnant mothers ceased in the 1990s following formal
advice from the Chief Medical Officer when the teratogenicity
of excessive vitamin A intake was appreciated(15). No provision
was made for continued vitamin D supplementation of pregnant
mothers. This left women dependent on the combination of a
national diet known to be poor in vitamin D and sun-induced
skin synthesis that is effective in increasing serum 25-hydroxy-
vitamin D (25(OH)D) concentrations only for 5–6 months of the
year(4,8). The benefits of modest supplementation of immigrant
mothers had been demonstrated in the UK by the 1990s(5,16),
suggesting that the resurgence of rickets was predictable and
largely preventable had routine vitamin D supplementation
been continued(5).
Current conflicts in advice
The UK Department of Health (DoH) re-enforced their
advice(17) for pregnant and breast-feeding mothers to ensure
that they achieved intakes of vitamin D (10mg/d (400 IU/d)) in
2007. This followed recommendations of the Scientific
Advisory Committee on Nutrition(8) (Table 2) and a resurgence
of rickets, especially in immigrant communities with high pre-
valence of vitamin D deficiency(3,18 – 21). DoH advice effectively
endorses supplementation as diet provides little vitamin D,
and sunlight-induced synthesis is limited in Britain(4,8).
The recent DoH re-enforcement of vitamin D supplemen-
tation in pregnancy coincided with a conflict in advice being
developed by the National Institute for Health and Clinical
Excellence on Antenatal Care (‘healthy pregnant mothers
should not be routinely supplemented with vitamin D’,
September 2007) and on Maternal and Child Nutrition (endor-
sing existing DoH guidelines, July 2007). The final recommen-
dation was made by the National Institute of Health and Clinical
Excellence Guideline Review Panel, and, in contrast to current
DoH guidance, it did not endorse vitamin D supplementation
for all pregnant women. Instead, it stated that ‘all women
should be informed. . . about the importance for their own and
their baby’s health of maintaining adequate vitamin D stores
during pregnancy and whilst breastfeeding’, and that ‘in order
to achieve this, women may choose to take 400 IU/d as in the
Healthy Start Multivitamin supplement’(22,23). Continuing con-
fusion in the UK recommendations is highlighted by the
inclusion of vitamin D as one of the vitamins to be provided
free of charge to low-income mothers as part of the Healthy
Start Scheme (previously known as the Welfare Food
Scheme), despite the relatively weak social differences in
vitamin D status seen in the UK(4) and the lack of systematic
implementation of vitamin D supplementation recommen-
dations for other pregnant mothers. There have also been
severe problems in the distribution of Healthy Start vitamins,
with manufacturing being stopped due to ‘lack of demand’(24).
Currently, the UK is the only one of the thirty-one European
countries with a recommended daily vitamin D intake of 0 for
women of child-bearing age(25), and therefore, the UK is doing
nothing to reduce the risk of women becoming vitamin D
deficient before they become pregnant.
Conflicting advice on maternal vitamin D intake is not unique
to the UK. The North American health authorities are debating,
Table 1. Barriers to adequate vitamin D intake and sunlight-induced skin synthesis in pregnancy
Factor affecting intake/synthesis Consequence
Diet is a poor source of vitamin D. Vitamin D content is high only in oily fish;
moderate in eggs; low in meat and supplemented breakfast cereals;
very poor in milk, butter and other dairy products unless fortified.
Margarine is routinely fortified in the UK, but only to the concentration
naturally present in butter
Insufficient intake of vitamin D through diet
SACN (2004) advice is to avoid eating oily fish of more than two portions per
week in pregnancy to avoid excessive intakes of harmful pollutants
(mainly, dioxins, polychlorinated biphenyls and mercury)(60).
Links (accessed on 1 August 2008): SACN:
http://www.sacn.gov.uk/pdfs/fics_sacn_advice_fish.pdf
Restricted dietary intake of vitamin D due to limited oily fish
consumption in pregnancy
UK Department of Health advice not to take cod liver oil in pregnancy
(since October 1990) to avoid excessive intakes of vitamin A content
due to shown teratogenicity(15)
Elimination of cod liver oil as a source of vitamin D during
pregnancy
Latitude Increasing declination of the sun with distance from the equator
reduces UVB reaching the earth’s surface
Dimming due to atmospheric dust clouds and/or pollution Reduces UVB reaching the earth’s surface
Clothing, in particular all-over clothing and veiling Reduces skin exposure to available UVB
Avoidance of sunlight to reduce skin cancer risks or to maintain/improve
appearance using hats, sunscreens and avoidance of sunlight between
11.00 and 15.00 hours
All reduce exposure to sunlight containing UVB effective for
inducing skin synthesis of vitamin D
Working indoors/shift work Reduced time spent outdoors during daylight hours, with window
glass blocking UVB radiation
Recreational habits: preference for indoor activities, such as watching television
and using computers over outdoor activities
Reduced exposure to UVB due to less time spent outdoors
Lack of outdoor exercise due to possible pregnancy-related restrictions Reduced exposure to UVB due to less time spent outdoors
Lack of holidays in the sun due to possible pregnancy-related travel restrictions Limited opportunity to boost vitamin D reserves to cover periods
of low synthesis in the latitude of residence
Periods of hospitalisation due to pregnancy-related complications Reduced exposure to UVB due to less time spent outdoors
SACN, Scientific Advisory Committee on Nutrition.
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not about whether to supplement vitamin D, but only about
the dosage of vitamin D that should be provided. The Canadian
Paediatric Society recently recommended that ‘all pregnant
mothers should take vitamin D 50mg/d (2000 IU/d) throughout
pregnancy’(26), while shortly afterwards, the Federal Depart-
ment of Health Canada re-enforced its recommendation of
5mg/d (200 IU/d) for pregnant and breast-feeding women,
publicly discounting the recommendations of the Paediatric
Society. Currently, the European Commission recommends
10mg/d (400 IU/d) vitamin D during pregnancy(27), while the
WHO recommendation is set at 5mg/d (200 IU/d)(28).
Gaps in the evidence and differences in its interpretation
Inconsistency in advice given by health authorities can arise
from differences in the interpretation of available evidence
and in the perceived importance of vitamin D deficiency in preg-
nancy. Furthermore, opinions about the safety of dosages .10
mg/d (400 IU/d) in pregnancy differ(8). As reviewed above, his-
torical data suggest that the recommended dosage of 10mg/d
(400 IU/d) is safe and effective in preventing severe clinical
vitamin D deficiency, rickets in children and osteomalacia in
adults(5,9). However, the physiological effects of 1,25-dihydroxy-
vitamin D (the active hormonal metabolite) are known to
extend beyond Ca metabolism and bone health, and evidence is
accumulating to suggest that vitamin D intakes required to
achieve optimal benefits are likely to be much higher(29,30).
Vitamin D in pregnancy
The importance of vitamin D during pregnancy is suggested by
the presence of nuclear vitamin D receptors and of the vitamin
D-activating 1-a-hydroxylase enzyme in pregnancy-specific
tissues such as the decidua and placenta(31). Circulating maternal
concentrations of 1,25-dihydroxyvitamin D rise from early in the
first trimester and increase progressively during gestation, being
twice as high in late pregnancy than postpartum or in non-
pregnant controls(31). These physiological changes are accepted
as important for ensuring fetal Ca supplies and for inducing
immunological adaptations required for successful main-
tenance of pregnancy(31). There is evidence for alterations in
vitamin D metabolism in women with pre-eclampsia(32–36),
with recent studies suggesting reductions in the incidence with
higher maternal vitamin D status(37) and intake(38). The immuno-
modulatory effects of 1,25-dihydroxyvitamin D, which have been
proposed to explain the associations with pre-eclampsia(36),
would also be biologically relevant for reduction in the risk of
miscarriage(39), and could explain the recent observations for
higher success rates for in vitro fertilisation for women with
higher compared to lower 25(OH)D concentrations(40).
Preliminary data from a randomised placebo controlled trial of
high-dose vitamin D supplementation in pregnancy (100mg/d,
presented in the Vitamin D Workshop in Bruges, October 2009)
suggested that supplementation at these dosages was safe and
did not lead to elevations in maternal Ca levels(41). They also
reported reductions in the rate of preterm births and pregnancy-
related complications. However, full evaluation of these data
will need to wait for the formal publication of the findings.
Maternal vitamin D deficiency and offspring health
Vitamin D status in neonates is related to maternal vitamin D
status (serum 25(OH)D)(20,42,43). Randomised trials show
maternal and cord 25(OH)D to increase after maternal vitamin D
supplementation(43–45). Neonatal complications of extreme
maternal vitamin D deficiency are life threatening (e.g. severe
hypocalcaemic fits with high risks of resultant brain damage(20)
and neonatal heart failure(46)) in addition to the well-recognised
Table 2. UK sources of current advice on vitamin D supplementation in pregnancy and conflicts on who should be supplemented
1998: Committee on Medical Aspects of Food and Nutrition Policy(17)
Reference nutrient intake for all pregnant and lactating women: 10mg/d (400 IU/d): recommendation was set in 1991 and endorsed in 1998.
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4005936*
2004: National Health Service. ‘Healthy start’(61)
Supplements containing 10mg/d of vitamin D offered free of charge to pregnant and breast-feeding women eligible under the Healthy Start Scheme.
Eligible women include pregnant women and families with children under the age of 4 years who are on income support, income-based jobseeker’s
allowance or who receive child tax credit with an income of £15 575 a year or less (2008/9). http://www.healthystart.nhs.uk/*
2007: Scientific Advisory Committee on Nutrition: Update on vitamin D(8)
Explicit reiteration that all pregnant and breast-feeding women should consider taking daily supplements of vitamin D, 10mg/d (400 IU/d), to ensure
their requirement for vitamin D is met and to ensure adequate fetal stores for early infancy. http://www.sacn.gov.uk/reports_position_statements/
position_statements/update_on_vitamin_d_-_november_2007.html*
2007: Department of Health Vitamin D Campaign
Encouragement to pregnant and breast-feeding women to boost their intake of vitamin D in the darker winter months, if necessary by taking
supplemental vitamin D (10mg as in Healthy Start Supplements). Women who consider themselves being at risk of vitamin D deficiency encouraged
to seek measurement of serum concentrations. http://www.wired-gov.net/wg/wg-news-1.nsf/0/651D8117086E1C76802573BF00267D65?Open
Document*
2008: National Institute of Health and Clinical Excellence(22,23)
Importance and benefits of maintaining adequate vitamin D storages to be made known to all pregnant and breast-feeding women at the booking
appointment, with advice that women may choose to take 10mg/d (400 IU/d). Particular focus to be given to high-risk women including the obese,
women with limited skin exposure to sunlight or who are of South Asian, African, Caribbean or Middle Eastern descent (in ‘Antenatal Care’, also
women who eat a diet particularly low in vitamin D), uptake of Healthy Start Supplements encouraged in those who are eligible. ‘Maternal and Child
Nutrition’ (March 2008): http://www.nice.org.uk/nicemedia/pdf/PH011guidance.pdf* ‘Antenatal Care’ (March 2008): http://www.nice.org.uk/nicemedia/
pdf/CG062NICEguideline.pdf
* All links are as accessed on 9 July 2009.
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risks of fractures and rickets. The evidence for the severe
complications of vitamin D deficiency comes from an expanding
series of case reports. For obvious ethical reasons, these rare com-
plications have not been, and they are unlikely ever to be, exam-
ined by randomised trials of supplementation. Indeed, experience
has already shown that trials proposing to randomise mothers
with low serum 25(OH)D concentrations are deemed unaccep-
table by most ethics committees, and approvals have been granted
only to investigate the influences of vitamin D supplementation
in women who are not severely deficient (serum 25(OH)D .25
nmol/l). Vitamin D insufficiency has been associated with
dose-wise reductions in bone mineral content in offspring(47)
and perinatal growth restriction(43), and also with increased
risk of immunological disorders such as type 1 diabetes(48,49)
and acute respiratory infection(50). The range of maternal and
offspring health outcomes associated with maternal vitamin D
status has been the subject of a number of recent reviews(51–54).
The only end-point for possible adverse effects of maternal
vitamin D ‘repletion’ is the association of high maternal
25(OH)D concentrations with increased atopy and asthma risks
in the offspring(55), which is a finding challenged by reports
suggesting beneficial effects of higher v. lower maternal vitamin
D intakes on early childhood wheezing(56). Overall, the available
evidence suggests unequivocal benefits for avoidance of vitamin
D deficiency during pregnancy, while the possible risks of milder
forms of hypovitaminosis D provide promising scope for the
prevention of a number of disorders. However, vitamin D dosages
required to reach serum concentrations currently considered
‘optimal’ for health are likely to be higher than 10mg/d(57,58)
and, as Scientific Advisory Committee on Nutrition and National
Institute of Health and Clinical Excellence state, larger dosages
in pregnancy require formal safety assessment(8,22,23).
The public health problem, what is being done and what
more should be done
As stated in the Scientific Advisory Committee on Nutrition
Update on Vitamin D(8), there is concern that vitamin D
‘recommendations are overlooked by health professionals, as
well as by the general public’, and further that the ‘uptake
of vitamin drops in the UK is very low even amongst those
entitled to receive free supplies’. The recent provision of
supplements containing 10mg (400 IU) of vitamin D to
pregnant/breast-feeding women and their offspring should
lead to improvements in the situation, provided that the
supply chain problems can be overcome(24).
British immigrants are recognised as at ‘high risk’ of
hypovitaminosis D, but the problem is also common in
pregnant White women, even when living in the Southern
England(47). As can be seen in Fig. 1, 90 % of white pregnant
mothers in the Avon Longitudinal Study of Parents and
Children(59) had 25(OH)D concentrations ,50 nmol/l during
winter and spring; 28 % were seriously deficient (,25 nmol/l),
and virtually no one reached 75 nmol/l (currently considered
optimal). Over the year, 60 % of expectant mothers (approxi-
mately 403 000 English/Welsh women) are likely to require
vitamin D supplementation for avoidance of serum
25(OH)D ,50 nmol/l (90 % being White). Over 150 000
mothers will have deficiency (,25 nmol/l), and 59 % of
these being White (estimated from data presented in Fig. 1
and published prevalence rates for non-White British immi-
grants(57)). As seen in Fig. 1, hypovitaminosis D in White
women in the UK is largely a problem during winter and
spring, suggesting that treatment during these seasons would
benefit most women.
The UK Health Minister emphasised (December 2007)
that ‘women should contact their GP for a blood test if they
think they may be lacking the vitamin’ (Table 2). However,
this approach does not allow for the high prevalence of
hypovitaminosis D, for the high cost of serum 25(OH)D
assays (currently approximately £10·50–£25 depending on
the assay and laboratory) or for the undesirability of delays
in starting supplementation while awaiting results. Indeed,
given the data that have been discussed already, it can be
argued that relatively little is gained by measuring individual
25(OH)D concentrations since routine supplementation of a
pregnant/breast-feeding woman at 10mg/d (400 IU/d) can
currently be provided for £3·64/year(24).
Conclusions
The prevalence of hypovitaminosis D in expectant mothers in
Britain is unacceptably high. We, therefore, suggest that all
pregnant mothers should be offered vitamin D supplementation
throughout the pregnancy to provide cheap, safe and effective
prevention of overt vitamin D deficiency. As shown by previous
UK experience(5,16), 10mg/d (400 IU/d) of vitamin D should
be enough to prevent the major bony and life-threatening
complications of severe clinical deficiency. Higher doses may
well be needed to achieve adequate neonatal vitamin D
repletion(25,57), but well-designed randomised controlled trials
are urgently needed to establish the potential benefits (and
safety) of higher maternal vitamin D intakes.
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